Bone Safety Profile of Steroidal Aromatase Inhibitor in Comparison to Nonsteroidal Aromatase Inhibitors in Postmenopausal Women with Breast Cancer: A Network Meta-Analysis

BACKGROUND AND OBJECTIVES: Aromatase inhibitors (AIs) provide an alternative to tamoxifen as an adjuvant therapy for postmenopausal patients with breast cancer (BC). Large trials resulted better outcomes with AIs. Adjuvant therapy with AIs reduced the risk of relapse compared with tamoxifen. Systemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shanshan, Bo, Lan, Lv, Dan, Ma, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453661/
https://www.ncbi.nlm.nih.gov/pubmed/36156912
http://dx.doi.org/10.1159/000523695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453661/
https://www.ncbi.nlm.nih.gov/pubmed/36156912
http://dx.doi.org/10.1159/000523695

Ejemplares similares